Medinotec Inc. (MDNC)
MDNC is quoted over the counter, not listed on an exchange. Medinotec Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | MDNC, quoted over the counter |
| SEC CIK | 0001931055 |
| OTC Markets tier | OTCQX (price source, 2026-11-13) |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Business address | Johannesburg |
| Incorporated in | NV |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. "Management has concluded that there is no substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the date these financial statements are issued." | 10-Q 2026-10-08 |
| Cash and burn | $2.6M cash; operating cash flow $93K a quarter. | Report 2026-08-31 |
| Shares outstanding | 11,755,548 (2026-10-08); 11,755,548 a year earlier; 11,733,750 three years earlier. | Cover page 2026-10-08 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Mercurius & Associates LLP, New Delhi, India | PCAOB Form AP 2026-06-01 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2027 2026-08-31 | $3.2M | $41K | $108K | $2.6M | No debt tags | $10.2M | 10-Q 2026-10-08 |
| Q1 2027 2026-05-31 | $2.7M | $222K | -$176K | $2.5M | No debt tags | $10.2M | 10-Q 2026-07-09 |
| Q4 2026 2026-02-28 | $1.8M | -$69K | -$121K | $2.8M | No debt tags | $9.7M | 10-K 2026-05-28 |
| Q3 2026 2025-11-30 | $2.5M | $403K | $563K | $2.9M | No debt tags | $11.4M | 10-Q 2026-01-09 |
| Q2 2026 2025-08-31 | $3.2M | $347K | $1.2M | $2.2M | No debt tags | $11.5M | 10-Q 2026-10-08 |
| Q1 2026 2025-05-31 | $2.1M | $114K | -$759K | $2.0M | No debt tags | $10.0M | 10-Q 2026-07-09 |
| Q4 2025 2025-02-28 | $3.5M | $1.5M | $99K | $2.8M | No debt tags | $9.1M | 10-K 2026-05-28 |
| Q3 2025 2024-11-30 | $2.6M | $310K | $125K | $2.7M | No debt tags | $7.9M | 10-Q 2026-01-09 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2022-11-18 |
| Latest annual report | 10-K | 2026-05-28 |
| Latest quarterly / interim | 10-Q | 2026-10-08 |
| Latest current report | 8-K | 2026-01-20 |
| Latest proxy | DEF 14A | 2026-01-02 |
Source: SEC EDGAR submissions feed, 54 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier